Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilar Deals 2025
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Diversity
Helen Macpherson
Intranet
Kimberley Evans
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

Novo Nordisk Launches Wegovy® in China

Nov 19, 2024

On 19 November 2024, Reuters reported that Novo Nordisk has launched Wegovy® (semaglutide) in China.  The report states that sales will initially be made without insurance subsidy, although Novo Nordisk is investigating mechanisms to reduce costs for Chinese consumers.

Novo Nordisk’s Wegovy® was approved by China’s National Medical Products Administration (NMPA) in June 2024.